首页>
外国专利>
Terazosin transdermal device and methods
Terazosin transdermal device and methods
展开▼
机译:特拉唑嗪透皮装置和方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
A method of effectively treating benign prostatic hypertension in humans is achieved by administering amorphous terazosin via a transdermal formulation. Preferably, the transdermal formulation is applied to the skin of the patient and maintained in contact with the skin for at least about 24 hours, and preferably for about 3 to about 8 days.
展开▼